Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : Nvs    crawled date : 2022 - 03 - 08    save search

Voyager Therapeutics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
Published: 2022-03-08 (Crawled : 17:00) - voyagertherapeutics.com
NVS | News | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
VYGR | $7.55 -2.46% -2.52% 1M twitter stocktwits trandingview |
Health Technology
| | O: 31.15% H: 19.58% C: 9.17%

therapeutics report results
Global RNA-Targeted Small Molecules Market to Witness 6.1% Growth during 2022 - 2030
Published: 2022-03-08 (Crawled : 16:00) - prnewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%

growth
Non-small Cell Lung Cancer Drugs Market to Grow by USD 30.23 billion| Increasing Prevalence and Incidence of Non-small Cell Lung Cancer to Boost Market Growth | Technavio
Published: 2022-03-08 (Crawled : 08:00) - prnewswire.com
AZNCF | $140.15 -4.19% 560 twitter stocktwits trandingview |
Health Technology
| | O: -2.09% H: 5.03% C: 0.85%
ALPMY | News | $9.46 -1.11% 500K twitter stocktwits trandingview |
Manufacturing
| | O: 1.01% H: 0.81% C: -0.06%
NVS | News | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.29% H: 0.6% C: -1.24%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 3.03% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.44% H: 0.0% C: 0.0%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.35% H: 0.0% C: 0.0%

drug cel lung cancer cancer drug cancer growth
Voyager Therapeutics Announces License Option Agreement with Novartis for Target-Specific Access to Next-Generation TRACER™ AAV Capsids for Gene Therapy Programs
Published: 2022-03-08 (Crawled : 07:00) - globenewswire.com
NVS | News | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: -4.98% H: 0.0% C: 0.0%
VYGR | $7.55 -2.46% -2.52% 1M twitter stocktwits trandingview |
Health Technology
| | O: 31.15% H: 19.58% C: 9.17%

trace novartis aav capsids gene therapy program license therapeutics therapy
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.